KNOTT DAVID M
Q1 2020 Form 13-F
SYOSSET, NEW YORK
CIK 0000808722
· Institutional investment manager
Consolidated report · includes
1 manager
since Q2 2013
$158.5M Reported Value Total
Reported value
$158.5M
Quarter over quarter
-33.2%
Holdings
120
Top-10 concentration
61.0%
Filing Structure
Reports holdings for
- DORSET MANAGEMENT CORP (not a 13F filer in our records) · File #028-10281 · since Q2 2013 · declared by one filing
Key People
Named on the latest Form 13-F filing — not necessarily an owner
Knott David M
Investment Manager
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2020 13F record
Q1 2020 13F filing summary
| Period of report | March 31, 2020 |
|---|---|
| Filed | May 13, 2020 |
| Form | 13F-HR |
| Reported value | $158.5M |
| Positions | 120 |
| Change in reported value | -35.8% |
| New positions | 19 |
| Exited positions | 10 |
| Position turnover | 22.3% |
| Top-10 concentration | 61.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2021 13F
Filed Nov 12, 2021
|
147 | $275.2M |
|
Q2 2021 13F
Filed Aug 13, 2021
|
144 | $281.3M |
|
Q1 2021 13F
Filed May 13, 2021
|
127 | $233.8M |
|
Q4 2020 13F
Filed Feb 12, 2021
|
107 | $221.0M |
|
Q3 2020 13F
Filed Nov 13, 2020
|
96 | $170.4M |
|
Q2 2020 13F
Filed Aug 12, 2020
|
90 | $183.2M |
|
Q1 2020 13F
Filed May 13, 2020
|
120 | $158.5M |
|
Q4 2019 13F
Filed Feb 14, 2020
|
112 | $246.7M |
|
Q3 2019 13F
Filed Nov 12, 2019
|
116 | $238.0M |
|
Q2 2019 13F
Filed Aug 12, 2019
|
109 | $237.1M |
|
Q1 2019 13F
Filed May 13, 2019
|
108 | $250.9M |
|
Q4 2018 13F
Filed Feb 12, 2019
|
100 | $212.8M |
|
Q3 2018 13F
Filed Nov 13, 2018
|
104 | $308.2M |
|
Q2 2018 13F
Filed Aug 13, 2018
|
108 | $266.8M |
|
Q1 2018 13F
Filed May 11, 2018
|
106 | $242.6M |
|
Q4 2017 13F
Filed Feb 13, 2018
|
108 | $251.4M |
|
Q3 2017 13F
Filed Nov 13, 2017
|
107 | $233.9M |
|
Q2 2017 13F
Filed Aug 11, 2017
|
89 | $239.6M |
|
Q1 2017 13F
Filed May 12, 2017
|
78 | $207.8M |
|
Q4 2016 13F
Filed Feb 13, 2017
|
69 | $198.7M |
14 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q1 2020
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | LGND Ligand Pharmaceuticals Incorporated | $25.7M | 16.2% |
| 2 | SRCL Stericycle, Inc. | $13.1M | 8.25% |
| 3 | APO Apollo Global Management, Inc. | $12.5M | 7.88% |
| 4 | UPLD Upland Software, Inc. | $11.1M | 6.99% |
| 5 | GOOG Alphabet Inc-Cl C | $9.2M | 5.8% |
| 6 | FTAI Fortress Trans & Infrastructure Inv. LLC | $7.3M | 4.6% |
| 7 | KKR KKR & Co. Inc. | $4.8M | 3.04% |
| 8 | FSK FS KKR Capital Corp. | $4.7M | 2.99% |
| 9 | PFE Pfizer Inc. | $4.3M | 2.72% |
| 10 | CCXI ChemoCentryx, Inc. | $4.0M | 2.55% |
| 11 | BRSL International Gaming Technologies | $3.6M | 2.28% |
| 12 | LKQ LKQ Corporation | $3.1M | 1.94% |
| 13 | ABBV AbbVie Inc. | $2.7M | 1.69% |
| 14 | BMY Bristol-Myers Squibb Company | $2.6M | 1.61% |
| 15 | BLU BELLUS Health Inc. | $2.4M | 1.53% |
| 16 | FNMAT Fannie Mae 8.25 percent Series T | $2.2M | 1.38% |
| 17 | CLMT Calumet Specialty Products Partners, LP | $2.1M | 1.34% |
| 18 | JPM JP Morgan Chase | $2.1M | 1.31% |
| 19 | XENE Xenon Pharmaceuticals Inc. | $2.0M | 1.25% |
| 20 | BDSI BioDelivery Sciences International, Inc. | $1.9M | 1.21% |
Values as reported on the Q1 2020 Form 13F. Every position is in the holdings table below.